Colony Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $7.29M | Buy |
27,144
+755
| +3% | +$188K | 0.11% | 176 |
|
|
2023
Q2 | $5.86M | Buy |
26,389
+648
| +3% | +$150K | 0.08% | 208 |
|
|
2023
Q1 | $6.22M | Sell |
25,741
-1,821
| -7% | -$447K | 0.09% | 206 |
|
|
2022
Q4 | $7.24M | Sell |
27,562
-2,249
| -8% | -$603K | 0.1% | 196 |
|
|
2022
Q3 | $6.72M | Buy |
29,811
+531
| +2% | +$129K | 0.12% | 168 |
|
|
2022
Q2 | $7.12M | Sell |
29,280
-490
| -2% | -$120K | 0.12% | 163 |
|
|
2022
Q1 | $7.2M | Buy |
29,770
+2,707
| +10% | +$622K | 0.11% | 171 |
|
|
2021
Q4 | $6.09M | Sell |
27,063
-879
| -3% | -$186K | 0.11% | 162 |
|
|
2021
Q3 | $5.94M | Sell |
27,942
-16,265
| -37% | -$3.74M | 0.11% | 158 |
|
|
2021
Q2 | $10.8M | Sell |
44,207
-18,000
| -29% | -$4.43M | 0.21% | 99 |
|
|
2021
Q1 | $15.5M | Sell |
62,207
-70,178
| -53% | -$16.7M | 0.33% | 80 |
|
|
2020
Q4 | $30.4M | Sell |
132,385
-5,124
| -4% | -$1.18M | 0.7% | 35 |
|
|
2020
Q3 | $34.9M | Buy |
137,509
+4,236
| +3% | +$1.05M | 0.91% | 24 |
|
|
2020
Q2 | $31.4M | Buy |
133,273
+4,650
| +4% | +$1.06M | 0.91% | 21 |
|
|
2020
Q1 | $26.1M | Sell |
128,623
-3,052
| -2% | -$667K | 0.85% | 22 |
|
|
2019
Q4 | $31.7M | Buy |
131,675
+4,835
| +4% | +$1.07M | 0.8% | 26 |
|
|
2019
Q3 | $24.5M | Buy |
126,840
+590
| +0.5% | +$113K | 0.78% | 28 |
|
|
2019
Q2 | $23.3M | Buy |
126,250
+13,402
| +12% | +$2.4M | 0.74% | 30 |
|
|
2019
Q1 | $21.4M | Sell |
112,848
-7,826
| -6% | -$1.49M | 0.9% | 26 |
|
|
2018
Q4 | $23.5M | Sell |
120,674
-648
| -0.5% | -$126K | 1.14% | 19 |
|
|
2018
Q3 | $25.1M | Sell |
121,322
-2,175
| -2% | -$429K | 1.26% | 17 |
|
|
2018
Q2 | $22.8M | Buy |
123,497
+19,057
| +18% | +$3.37M | 1.19% | 17 |
|
|
2018
Q1 | $17.8M | Buy |
104,440
+3,317
| +3% | +$609K | 0.97% | 22 |
|
|
2017
Q4 | $17.6M | Buy |
101,123
+1,099
| +1% | +$194K | 1.1% | 19 |
|
|
2017
Q3 | $18.6M | Sell |
100,024
-2,385
| -2% | -$423K | 1.27% | 15 |
|
|
2017
Q2 | $17.6M | Buy |
102,409
+16,760
| +20% | +$2.73M | 1.26% | 15 |
|
|
2017
Q1 | $14.1M | Buy |
85,649
+47,735
| +126% | +$7.93M | 1.32% | 17 |
|
|
2016
Q4 | $5.54M | Sell |
37,914
-28,301
| -43% | -$4.26M | 0.59% | 53 |
|
|
2016
Q3 | $11M | Sell |
66,215
-626
| -0.9% | -$106K | 1.23% | 26 |
|
|
2016
Q2 | $10.2M | Buy |
66,841
+63,770
| +2,077% | +$9.91M | 1.12% | 35 |
|
|
2016
Q1 | $460K | Buy |
3,071
+207
| +7% | +$30.8K | 0.05% | 173 |
|
|
2015
Q4 | $465K | Sell |
2,864
-708
| -20% | -$111K | 0.04% | 262 |
|
|
2015
Q3 | $494K | Buy |
3,572
+289
| +9% | +$45.6K | 0.06% | 245 |
|
|
2015
Q2 | $504K | Buy |
3,283
+274
| +9% | +$43.9K | 0.05% | 266 |
|
|
2015
Q1 | $481K | Buy |
3,009
+53
| +2% | +$8.35K | 0.05% | 223 |
|
|
2014
Q4 | $471K | Sell |
2,956
-860
| -23% | -$134K | 0.05% | 256 |
|
|
2014
Q3 | $536K | Buy |
3,816
+264
| +7% | +$34.5K | 0.06% | 228 |
|
|
2014
Q2 | $420K | Sell |
3,552
-265
| -7% | -$30.7K | 0.06% | 169 |
|
|
2014
Q1 | $471K | Buy |
3,817
+75
| +2% | +$9.1K | 0.06% | 169 |
|
|
2013
Q4 | $427K | Buy |
+3,742
| New | +$426K | 0.06% | 170 |
|
Other funds holding AMGN
Colony Group's AMGN Position: Q3 2023 in Review
Colony Group increased its Amgen (AMGN) stake by 2.9% in Q3 2023, buying an estimated $188K and bringing the position to 27,144 shares worth $7.29M. The position accounts for 0.11% of the portfolio, ranked #176.
Colony Group first reported a position in AMGN in Q4 2013 and has held it in 40 quarters since. The position peaked at $34.9M in Q3 2020. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Colony Group held 27,144 shares of Amgen worth $7.29M as of Q3 2023.
- Colony Group bought 755 Amgen shares in Q3 2023, an estimated $188K.
- Amgen made up 0.11% of Colony Group's portfolio in Q3 2023, its #176 holding.
- Colony Group first reported a position in Amgen in Q4 2013 and has held it in 40 quarters since.
- Colony Group's Amgen position peaked at $34.9M in Q3 2020.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.